Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants | --- | |------------------------------------------------| | | | | | Louise Wilkie - Investor Relations | | Sandy Macrae - Chief Executive Officer | | Rob Schott - Head of Development | | Jason Fontenot - Chief Scientific Officer | | Prathyusha Duraibabu - Chief Financial Officer | | Bettina Cockroft - Chief Medical Officer | | Mark McClung - Chief Operating Officer | | Conference Call Pa ...